Generics Industry Offers Substitution, Not Rebates, As Health Reform Savings Proposal
This article was originally published in The Pink Sheet Daily
Executive Summary
Giving states incentives to boost Medicaid's use of generic drugs would produce more savings than Sen. Baucus' rebate proposals, Teva argues.
You may also be interested in...
Senate Bill Aims To Incentivize Generic Substitution In Medicaid
Bipartisan bill would rebate 50% of savings to states who improve generic utilization rates year-over-year through fiscal 2014.
Senate Bill Aims To Incentivize Generic Substitution In Medicaid
Bipartisan bill would rebate 50% of savings to states who improve generic utilization rates year-over-year through fiscal 2014.
Health Reform Markup: Some Amendments Will Seek Higher Fees On Drug Firms
Senate Finance Committee will begin marking up its health reform bill Sept. 22.